*Virtual* Techstars Healthcare powered by Permanente Medicine Mid-Atlantic States Demo Day 2026
From Innovation to Impact: Advancing the Future of Care Delivery
The future of healthcare depends on how effectively innovation is translated into clinical care.
Permanente Medicine Mid-Atlantic States, in partnership with Techstars, is advancing a model that integrates clinical excellence, rigorous evaluation, and purposeful innovation to drive meaningful, scalable change in how care is delivered.
This session will convene a curated group of leaders to engage with the latest class from the Techstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic States: nine startups selected from more than 1,200 applicants for their potential to transform care delivery. They have spent three months working with our physicians and mentors to accelerate their path toward clinical adoption and real-world impact.
You will hear a brief overview of each company from its CEO, and following the presentations, we will host an exclusive Innovation Showcase and Reception, where you can meet the founders from both the 2026 and 2025 classes, along with your peers in leadership.
Our 2026 Class:
Arcus Dental is developing an at-home digital dental imaging platform designed to expand access to preventive dental care while keeping patients connected to their dentists.
Brainbox enables extremely early detection of cognitive decline using only language as input, helping identify individuals who may benefit from earlier evaluation and intervention.
DICEtech is developing an MRI-based virtual biopsy designed to reduce reliance on invasive biopsy in the prostate cancer diagnostic pathway.
Edulis Therapeutics is a Carnegie Mellon spinout building a sustained drug-delivery platform for chronic gastrointestinal diseases.
One Small Step is an AI-enabled marketplace connecting people with addiction and serious mental illness to certified on-demand peer-support services.
Otos Health is a physician-directed hearing and cognitive health platform for same-day assessment, action, and longitudinal monitoring in any clinic setting.
Rosalind Dx is developing an accessible prenatal screening platform designed to expand detection of chromosomal abnormalities during pregnancy.
SilkMed develops sprayable silk-based biomaterials for more effective treatment of complex burn and wound-care injuries.
SQK develops QMEDIC, a physics-guided AI solution for low-dose CT reconstruction that improves image quality while preserving clinically important details.
We look forward to bringing leaders together at a pivotal moment for our industry.
Agenda
5:30 PM – Program begins: welcome and company pitches
7:00 PM – Virtual program ends
Hosted by
Keith Camhi, Techstars Managing Director
Mason Gunter, Techstars Investment Manager
Ameya Kulkarni, MD, FSCAI, Executive Medical Director, Permanente Medicine Mid-Atlantic States
Jessica Locke, Chief Administrative and Innovation Officer, Permanente Medicine Mid-Atlantic States
Questions
If you have any questions, please contact Mason Gunter at mason.gunter@techstars.com.
By registering for this event, you are agreeing to Techstars' Terms of Use, Code of Conduct and Privacy Policy. If you have questions on these policies, please reach out to privacy@techstars.com.